Severity Assessment in CDKL5 Deficiency Disorder.
Scott Demarest, Elia M Pestana-Knight, Heather E Olson...
https://pubmed.ncbi.nlm.nih.gov/31147226/Actively Recruiting
Led by Children's Hospital of Philadelphia · Updated on 2025-10-29
600
Participants Needed
5
Research Sites
17 weeks
Total Duration
This research aims to understand more about disorders related to the STXBP1 and SYNGAP1 genes, which cause differences in brain synaptic transmission leading to developmental delays, epileptic encephalopathies, and complex behavioral and psychiatric disorders. The study seeks to define the clinical spectrum of these genetic conditions through detailed assessments as part of routine clinical care, preparing for future clinical treatment trials. Participants will be involved in a non-interventional, observational natural history study lasting up to five years, with up to 10 study visits. These visits include detailed health and medical history questions, physical exams, EEG or quantitative EEG tests, and age-appropriate neurodevelopmental and behavioral assessments. Assessments are conducted at the baseline visit and then every six months for 2 to 5 years. During the study, participants will undergo evaluations of their development, seizures, and quality of life. Researchers will monitor changes in clinical assessment percentiles over time and assess the burden of disease and testing on participants, caregivers, and clinical staff. The study also tracks healthcare resource use, with all procedures occurring during regularly scheduled clinic visits.
CONDITIONS
STXBP1 and SYNGAP1 Related Disorders Natural History Study
J
Joeylynn Nolan, RRT NPS AE-C
V
Victoria Chisari, BA, NS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Children's Hospital of Philadelphia
Lead Sponsor
STXBP1 Foundation
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 5 years
Participants undergo assessments of neurodevelopmental and behavioral function, as well as quality of life, during regularly scheduled clinic visits.
Up to 10 visits occurring approximately every 6 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Scott Demarest, Elia M Pestana-Knight, Heather E Olson...
https://pubmed.ncbi.nlm.nih.gov/31147226/Hsiang-Hui Wang, Hua-Fang Liao, Ching-Lin Hsieh
https://pubmed.ncbi.nlm.nih.gov/17012639/Julie Xian, Shridhar Parthasarathy, Sarah M Ruggiero...
https://pubmed.ncbi.nlm.nih.gov/35190816/Ping Yang, Robert Broadbent, Chitra Prasad...
https://pubmed.ncbi.nlm.nih.gov/35002943/Children's Hospital of Philadelphia
Lead Sponsor
STXBP1 Foundation
Collaborating Sponsor